日本語View as Markdown

Di-chlorido-{()-,-dimethyl-2-[phen-yl(pyridin-2-yl)methyl-idene]hydrazine-1-carbo-thio-amide}cadmium(II).

ジクロリド-{3,3-ジメチル-2-[フェニル(ピリジン-2-イル)メチリデン]ヒドラジン-1-カルボチオアミド}カドミウム(II)の結晶構造解析

other not specified not assessed

Abstract

This study reports the crystal structure of a 1:1 complex formed between the organic ligand Bp44mT (3,3-dimethyl-1-[(E)-[phenyl(pyridin-2-yl)methylidene]amino]thiourea) and cadmium chloride, determined at 100 K. The compound adopts monoclinic (2/m) symmetry with a layered arrangement. No intramolecular or intermolecular hydrogen bonding was detected; instead, supramolecular cohesion arises from hydrophobic contacts, π-π stacking, and long-range dispersion forces. The ligand is of interest for its anticancer and antiviral properties, as well as its potential in iron-overload conditions such as hemochromatosis, sickle cell disease, and beta thalassemia. The investigation also explores the structural basis of chelation selectivity and the possible application of the ligand in heavy metal poisoning involving cadmium, arsenic, lead, or mercury, and in environmental remediation contexts.

Mechanism

The ligand Bp44mT coordinates to cadmium ions to form a chelate complex; the crystal structure provides a basis for understanding the selectivity of metal ion capture relevant to heavy metal sequestration.

Bibliographic

Authors
Parry CS, Kwabi-Addo B, Ramadhar TR, Butcher RJ
Journal
IUCrdata
Year
2025
PMID
40487503
DOI
10.1107/S241431462500464X
PMC
PMC12142383

Tags

Disease:重金属毒性

Delivery context

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

Safety notes

The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 40487503. https://h2-papers.org/en/papers/40487503
Source: PubMed PMID 40487503